Universal Public Finance of Tuberculosis Treatment in India: An Extended Cost‐Effectiveness Analysis

E-ISSN： 1099-1050|24|3|318-332

ISSN： 1057-9230

Source： HEALTH ECONOMICS, Vol.24, Iss.3, 2015-03, pp. : 318-332

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost‐effectiveness Analysis and Insurance Coverage: Solving a Puzzle

HEALTH ECONOMICS, Vol. 24, Iss. 5, 2015-05 ,pp. : 506-515

John Wiley & Sons Inc

Access to resources Recommend Favorite

Skills of the Trade: The Tufts Cost-Effectiveness Analysis Registry

Journal of Benefit-Cost Analysis, Vol. 3, Iss. 1, 2012-01 ,pp. : 1-9

Cambridge University Press

Access to resources Recommend Favorite

Objections to the use of cost-effectiveness analysis in the US: reflecting on ‘Has the time come for cost-effectiveness analysis in US health care?’

Health Economics, Policy and Law, Vol. 10, Iss. 4, 2015-04 ,pp. : 419-424

Cambridge University Press

Access to resources Recommend Favorite

A Bayesian Net Benefit Approach to Cost-effectiveness Analysis in Health Technology Assessment

By Moreno Elias Giron Francisco Javier Vazquez-Polo Francisco Jose Negrin Miguel

International Journal of the Economics of Business, Vol. 16, Iss. 3, 2009-11 ,pp. : 323-345

Routledge Ltd

Access to resources Recommend Favorite

Has the time come for cost-effectiveness analysis in US health care?

Health Economics, Policy and Law, Vol. 4, Iss. 4, 2009-10 ,pp. : 425-443

Cambridge University Press

Access to resources Recommend Favorite